Market Overview

Zynerba Pharmaceuticals (NASDAQ: ZYNE)

5.57 -0.16 (-2.79%)

Analyst Ratings

DateResearch FirmActionCurrentPT
10/21/19NeedhamInitiates Coverage OnBuy18.0
9/16/19JefferiesAssumesHold11.0
4/30/19Roth CapitalInitiates Coverage OnBuy
4/22/19Canaccord GenuityAssumesBuy18.0
9/21/18Cantor FitzgeraldInitiates Coverage OnOverweight21.0
8/03/18Canaccord GenuityMaintainsBuy15.0
2/01/18H.C. WainwrightAssumesBuy23.0
1/29/18Ladenburg ThalmannInitiates Coverage OnBuy25.5
1/26/18Seaport GlobalInitiates Coverage OnBuy16.0
10/02/17Cantor FitzgeraldUpgradesOverweight

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter